ADHD

Texas accuses Pfizer and contract manufacturer of providing ineffective ADHD drug to state's Medicaid program
Texas accuses Pfizer and contract manufacturer of providing ineffective ADHD drug to state's Medicaid program
Fierce Pharma
Pfizer
Tris Pharma
ADHD
Texas
Medicaid
Flag link:
Otsuka reports positive data from two Phase III ADHD treatment trials
Otsuka reports positive data from two Phase III ADHD treatment trials
Clinical Trials Arena
Otsuka
clinical trials
ADHD
centanafadine
Flag link:
ADHD medication errors jumped 300% since 2000
ADHD medication errors jumped 300% since 2000
Medical Marketing and Media
ADHD
Flag link:
Akili cuts 40% of workforce, plans shift to non-prescription model
Akili cuts 40% of workforce, plans shift to non-prescription model
BioPharma Dive
Akili Interactive
digital therapeutics
digital health
Medtech
layoffs
ADHD
Flag link:
Supernus Announces New Qelbree Data Showing Improvement in ADHD Symptoms
Supernus Announces New Qelbree Data Showing Improvement in ADHD Symptoms
Drugs.com
Supernus
Qelbree
clinical trials
ADHD
Flag link:
DEA, FDA outline steps to mitigate ADHD drug shortage
DEA, FDA outline steps to mitigate ADHD drug shortage
The Hill
DEA
FDA
ADHD
drug shortages
Flag link:
ADHD Medication Shortage Worsens, Vyvanse Supply Dwindles Amid Adderall Scarcity
ADHD Medication Shortage Worsens, Vyvanse Supply Dwindles Amid Adderall Scarcity
Yahoo/Benzinga
ADHD
Vyvanse
drug shortages
Takeda
Flag link:
Drugmakers are abandoning cheap generics, and now US cancer patients can’t get meds
Drugmakers are abandoning cheap generics, and now US cancer patients can’t get meds
Medical Marketing and Media
generics
cancer
drug shortages
ADHD
antibiotics
Cisplatin
carboplatin
Flag link:
Akili cuts about 30% of staff in effort to be 'extremely lean'
Akili cuts about 30% of staff in effort to be 'extremely lean'
Endpoints
Akili Interactive
Medtech
ADHD
layoffs
video games
Flag link:
Adderall supply woes continue as the FDA confirms shortage of immediate release capsules
Adderall supply woes continue as the FDA confirms shortage of immediate release capsules
Endpoints
FDA
drug shortages
Adderall
ADHD
Flag link:
Sun, Camber join growing list of companies reporting Adderall supply problems
Sun, Camber join growing list of companies reporting Adderall supply problems
Fierce Pharma
ADHD
Adderall
drug shortages
Sandoz
Sun Pharma
Novartis
Flag link:
MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda ADHD drugs
MHRA raises concerns with switching between long-acting J&J, Novartis and Takeda ADHD drugs
Fierce Pharma
Takeda
JNJ
Novartis
ADHD
MHRA
Concerta XL
Ritalin XL
Equasym XL
Flag link:
FDA approves expanded indication for Supernus’ Qelbree for ADHD
FDA approves expanded indication for Supernus’ Qelbree for ADHD
Pharmaceutical Business Review
Supernus Pharmaceuticals
Qelbree
ADHD
FDA
Flag link:
Vallon's abuse-resistant Adderall fails clinical trial, causing stock to crater
Vallon's abuse-resistant Adderall fails clinical trial, causing stock to crater
Fierce Biotech
Vallon Pharmaceuticals
ADAIR
Adderall
ADHD
clinical trials
Flag link:
New study shows first FDA-cleared video game treatment for pediatric ADHD improves brain function
New study shows first FDA-cleared video game treatment for pediatric ADHD improves brain function
MedCity News
EndeavorRx
ADHD
Medtech
video games
Flag link:
IPO filings are back on the biotech menu as an ADHD drug developer submits its Nasdaq paperwork
IPO filings are back on the biotech menu as an ADHD drug developer submits its Nasdaq paperwork
Endpoints
IPOs
ADHD
Cingulate
Flag link:
Takeda Settles "Pay-for-Delay" Consumer Claims for $1.85 Million
Takeda Settles "Pay-for-Delay" Consumer Claims for $1.85 Million
BioSpace
Takeda
pay-for-delay
ADHD
generics
Flag link:
Supernus gears up for Q2 Qelbree launch, in time for back-to-school ADHD script season
Supernus gears up for Q2 Qelbree launch, in time for back-to-school ADHD script season
Fierce Pharma
Supernus Pharmaceuticals
Qelbree
ADHD
drug launches
Flag link:
FDA Approves Novel Non-Stimulant Treatment for ADHD
FDA Approves Novel Non-Stimulant Treatment for ADHD
BioSpace
Supernus Pharmaceuticals
ADHD
FDA
pediatric
Qelbree
Flag link:
KemPharm Snags Approval for ADHD Prodrug
KemPharm Snags Approval for ADHD Prodrug
BioSpace
KemPharm
ADHD
prodrugs
FDA
Azstarys
Flag link:

Pages